Medpage Today on MSN11d
Clotting Risk Worse Than Expected in Protein S-Deficient Patients
Protein S is a key vitamin K-dependent plasma protein involved in the regulation of coagulation. Deficiency of protein S, ...
Medscape6d
Pharmacologic Prophylaxis Against Venous Thromboembolism in Hospitalized Patients With Cirrhosis and Associated Coagulopathies
Purpose Published evidence on the incidence and predictors of venous thromboembolism (VTE) in patients with cirrhosis of the liver is reviewed. Summary The frequently observed phenomenon of ...
Medscape16y
Clinical Evidence for Rebound Hypercoagulability After Discontinuing Oral Anticoagulants for Venous Thromboembolism
Objective: Assess the extent to which rebound hypercoagulability-related VTE recurrences occur in the 2 months following discontinuation of OACs. Data sources: Published, randomized controlled ...
MedPage Today1mon
Some Contraceptives Carry Higher Venous Thromboembolism Risk Than Others
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Risk of VTE among different hormonal contraceptives varied by method and dose. Combined pills and injections had the ...
Monthly Prescribing Reference28d
Venous Thromboembolism Risk Higher for Certain Hormonal Contraceptives
The researchers found that per 10,000 person-years, the standardized VTE rates were 2.0, 10.0, 8.0, 8.1, 3.6, 2.1, 3.4, and 11.9 for nonuse, combined pills, vaginal ...